You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Patent: 5,011,678

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,011,678

Title:	Composition and method for administration of pharmaceutically active substances
Abstract:	Pharmaceutically active substances are administered in aerosol form by applying to a mucosal surface of the body a composition comprising a medically effective amount of a pharmaceutically active substance, a biocompatible amphiphilac steroid and a bicompatible (hydro/fluoro)carbon propellant.
Inventor(s):	Wang; Yu-chang J. (Los Altos, CA), Lee; William A. (Los Altos, CA), Narog; Blair (Palo Alto, CA)
Assignee:	California Biotechnology Inc. (Mountain View, CA)
Application Number:	07/305,520
Patent Claims:	see list of patent claims

Details for Patent 5,011,678

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Baxter Hlthcare Corp	MYXREDLIN	insulin human	SOLUTION;INTRAVENOUS	208157	001	2019-06-20	Start Trial	California Biotechnology Inc. (Mountain View, CA)	2039-02-26	RX		search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	004	2015-01-23	Start Trial	California Biotechnology Inc. (Mountain View, CA)	2039-02-26	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	003	2015-01-23	Start Trial	California Biotechnology Inc. (Mountain View, CA)	2039-02-26	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	002	2015-01-23	Start Trial	California Biotechnology Inc. (Mountain View, CA)	2039-02-26	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23	Start Trial	California Biotechnology Inc. (Mountain View, CA)	2039-02-26	RX	Orphan	search
Lilly	HUMULIN R PEN	insulin recombinant human	INJECTABLE;INJECTION	018780	005	1982-12-02	Start Trial	California Biotechnology Inc. (Mountain View, CA)	2039-02-26	RX		search
Lilly	HUMULIN R	insulin human	SOLUTION;SUBCUTANEOUS	018780	004	1982-12-02	Start Trial	California Biotechnology Inc. (Mountain View, CA)	2039-02-26	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 5,011,678

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	9009167	Start Trial
Australia	5159490	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

AstraZeneca

McKinsey

Johnson and Johnson

Colorcon

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.